Literature DB >> 3947013

Use of the rhomboid flap in pilonidal sinus.

B R Gwynn.   

Abstract

Our experiences with transposed rhomboid flaps in the treatment of pilonidal disease are described. Results show that primary healing occurred in all twenty patients in our series, with a maximum inpatient hospital stay of four days. A single recurrent sinus has occurred during a follow-up time of eighteen months.

Entities:  

Mesh:

Year:  1986        PMID: 3947013      PMCID: PMC2498181     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  9 in total

1.  THE ELIMINATION OF CAUSAL FACTORS IN PILONIDAL SINUS TREATED BY Z-PLASTY.

Authors:  R S MONRO; F T MCDERMOTT
Journal:  Br J Surg       Date:  1965-03       Impact factor: 6.939

2.  The aetiology and treatment of pilonidal sinus. A review of 163 patients.

Authors:  P GOODALL
Journal:  Br J Surg       Date:  1961-09       Impact factor: 6.939

3.  Treatment of pilonidal sinus by Z-plasty.

Authors:  M D Middleton
Journal:  Br J Surg       Date:  1968-07       Impact factor: 6.939

4.  Pilonidal sinus: a 5-year appraisal of the Millar-Lord treatment.

Authors:  M H Edwards
Journal:  Br J Surg       Date:  1977-12       Impact factor: 6.939

5.  A comparative study between Z-plasty and incision and drainage or excision with marsupialization for pilonidal sinuses.

Authors:  W J Hodgson; R J Greenstein
Journal:  Surg Gynecol Obstet       Date:  1981-12

6.  Use of the Limberg flap to close breast wounds after partial mastectomy.

Authors:  B R Gwynn; C R Williams
Journal:  Ann R Coll Surg Engl       Date:  1985-07       Impact factor: 1.891

7.  Radical cure of pilonidal sinus by a transposition rhomboid flap.

Authors:  A S Azab; M S Kamal; R A Saad; K A Abou al Atta; N A Ali
Journal:  Br J Surg       Date:  1984-02       Impact factor: 6.939

8.  A method for primary reconstruction following radical excision of sacrococcygeal pilonidal disease.

Authors:  R H Fishbein; J C Handelsman
Journal:  Ann Surg       Date:  1979-08       Impact factor: 12.969

9.  Excision and grafting in treatment of recurrent pilonidal sinus disease.

Authors:  B Guyuron; M I Dinner; R V Dowden
Journal:  Surg Gynecol Obstet       Date:  1983-02
  9 in total
  7 in total

1.  The treatment of pilonidal disease: guidelines of the Italian Society of Colorectal Surgery (SICCR).

Authors:  D Segre; M Pozzo; R Perinotti; B Roche
Journal:  Tech Coloproctol       Date:  2015-09-16       Impact factor: 3.781

Review 2.  German national guideline on the management of pilonidal disease.

Authors:  I Iesalnieks; A Ommer; S Petersen; D Doll; A Herold
Journal:  Langenbecks Arch Surg       Date:  2016-06-16       Impact factor: 3.445

3.  'D' excision for sacrococcygeal pilonidal sinus disease.

Authors:  C V Mann; R Springall
Journal:  J R Soc Med       Date:  1987-05       Impact factor: 18.000

4.  Common surgical procedures in pilonidal sinus disease: A meta-analysis, merged data analysis, and comprehensive study on recurrence.

Authors:  V K Stauffer; M M Luedi; P Kauf; M Schmid; M Diekmann; K Wieferich; B Schnüriger; D Doll
Journal:  Sci Rep       Date:  2018-02-15       Impact factor: 4.379

5.  Impact of geography and surgical approach on recurrence in global pilonidal sinus disease.

Authors:  Dietrich Doll; Andriu Orlik; Katharina Maier; Peter Kauf; Marco Schmid; Maja Diekmann; Andreas P Vogt; Verena K Stauffer; Markus M Luedi
Journal:  Sci Rep       Date:  2019-10-22       Impact factor: 4.379

Review 6.  German National Guideline on the management of pilonidal disease: update 2020.

Authors:  I Iesalnieks; A Ommer; A Herold; D Doll
Journal:  Langenbecks Arch Surg       Date:  2021-05-05       Impact factor: 3.445

7.  Consensus statement of the Italian society of colorectal surgery (SICCR): management and treatment of pilonidal disease.

Authors:  R Perinotti; G Gallo; M Milone; L Basso; M Manigrasso; R Pietroletti; A Bondurri; M La Torre; G Milito; M Pozzo; D Segre
Journal:  Tech Coloproctol       Date:  2021-06-27       Impact factor: 3.781

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.